Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative - 01/10/24

Doi : 10.1016/j.jbspin.2024.105733

Adeline Ruyssen-Witrand ^a,^⁎ , Damien Caillet-Portillo ^b, Aurélie Najm ^c, Olivier Fogel ^d, Athan Baillet ^e, Pascal Claudepierre ^f, Orenella Conort ^g, Emmanuelle Dernis ^h, Françoise Fayet ⁱ, Laure Gossec ^j, Philippe Goupille ^k, Christophe Hudry ^l, Jean-Guillaume Letarouilly ^m, Cédric Lukas ⁿ, Hubert Marotte ^o, Anna Molto ^p, Sophie Pouplin ^q, Eric Senbel ^r, Christelle Sordet ^s, Anne Tournadre ^t, Marie-Elise Truchetet ^u,^v, Daniel Wendling ^w, Maxime Dougados ^x
^a Rheumatology Centre, Toulouse University Hospital, Centre d’Investigation Clinique de Toulouse (CIC1436), Inserm, Team PEPSS “Pharmacologie En Population cohorteS et biobanqueS”, University of Toulouse 3, Toulouse, France
^b Rheumatology Centre, Toulouse University Hospital, University of Toulouse 3, Toulouse, France
^c Institute of Infection and Immunity, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
^d Department of Rheumatology, Hôpital Cochin, Assistance publique–Hôpitaux de Paris, Paris, France
^e Université Grenoble-Alpes, TIMC, CNRS UMR5525, Grenoble, France
^f AP–HP, Service de Rhumatologie, Hôpital Henri-Mondor, Université Paris Est Créteil, EA 7379, EpiDermE, Paris, France
^g Department Clinical Pharmacy, Hôpital Cochin, Assistance publique–Hôpitaux de Paris, Paris, France
^h Department of Rheumatology and Clinical Immunology, General hospital Le Mans, Le Mans, France
ⁱ Rheumatology Centre, Clermont University Hospital, Clermont-Ferrand, France
^j Sorbonne Université, Inserm, Institut Pierre-Louis d’Épidémiologie et de Santé Publique, AP–HP, Pitié-Salpêtrière Hospital, Rheumatology Department, Paris, France
^k Université de Tours, EA 6295, Department of Rheumatology, University Hospital of Tours, Tours, France
^l Institut Mutualiste Montsouris, Paris, France
^m University of Lille, CHU de Lille, FHU PRECISE, Rheumatology Department, Lille, France
ⁿ Department of Rheumatology, University Hospital of Montpellier, Inserm UA11 (IDESP), University of Montpellier, Montpellier, France
^o Université Jean-Monnet Saint-Étienne, CHU de Saint-Étienne, Service de Rhumatologie, Mines Saint-Étienne, Inserm, SAINBIOSE U1059, 42023 Saint-Étienne, France
^p ECAMO team (Inserm U1153), Center of Research in Epidemiology and Statistics (CRESS), Université Paris-Cité, Paris, France
^q Rheumatology Centre, Rouen University Hospital, Rouen, France
^r Centre de Rhumatologie de l’Eldorado, Marseille, France
^s Rheumatology Center, Strasbourg University Hospital, University of Strasbourg, Strasbourg, France
^t Rheumatology Centre, Clermont University Hospital, UNH INRAe University Clermont Auvergne, Clermont-Ferrand, France
^u Department of Rheumatology, Hôpital Pellegrin, Bordeaux, France
^v Bordeaux University, CNRS, ImmunoConcept, UMR 5164, 33000 Bordeaux, France
^w Rheumatology Centre, CHU de Besançon, University Hospital, EA4266, Université de Franche-Comté, Besançon, France
^x University of Paris-Cité, Department of Rheumatology, Hôpital Cochin, Assistance publique–Hôpitaux de Paris, Inserm (U1153): Clinical epidemiology and biostatistics, PRES Sorbonne Paris-Cité, Paris, France

^⁎Corresponding author. Rheumatology Center, Purpan Teaching Hospital, 1, place du Dr-Baylac, 31059 Toulouse cedex 9, France.Rheumatology Center, Purpan Teaching Hospital1, place du Dr-BaylacToulouse cedex 931059France

Highlights

•	An annual review of patients with axial spondyloarthritis encompassing disease activity, severity, comorbidities, employment, psychological factors, and lifestyle is recommended.
•	The specific content of this annual review has never been proposed.
•	This initiative provided a reporting framework including all components needing to be assessed during this review.
•	This document was obtained after a literature search and an expert consensus-driven approach.

Le texte complet de cet article est disponible en PDF.

Abstract

Introduction

National and international scientific societies advocate for a regular, systematic, and standardized global evaluation of axial spondyloarthritis (axSpA) patients. However, there are no recommendations specifying the content of this global evaluation. This initiative aimed to propose a standardized reporting framework, using evidence-based and consensus approaches, to collect data on all domains of axSpA.

Methods

A literature review and consensus process involved a steering committee and an expert panel of 37 rheumatologists and health professionals. The first steering committee took place in March 2022 and identified the main domains for inclusion in the standardized report. A hierarchical literature review was conducted to identify items within these domains and tools for assessment. The items and tools for assessment were discussed and consensus was reached through a vote session during an expert meeting that took place in March 2023.

Results

The steering committee identified four main domains to include in the standardized reporting framework: disease assessment, comorbidities, lifestyle, and quality of life. Items and tools for assessment were adopted after the expert meeting. Additionally, recommendations regarding digital tools (websites, apps, social media) were provided.

Conclusion

This initiative led to a consensus, based on evidence and expertise, on a reporting framework for use during periodic systematic global evaluations of axSpa in daily practice.

Le texte complet de cet article est disponible en PDF.

Keywords : Spondyloarthritis, Disease assessment, Comorbidities, Quality of life, E-health

Plan

Introduction

Methods

Decisions on the domains and contents of the holistic evaluation that had to be discussed

Hierarchical systematic literature review

Systematic review of digital tools for information of the patients

Consensus process

Finalization of the report frame and assessment of feasibility

Results

Hierarchical systematic literature analysis

Disease evaluation

Comorbidity reporting

Lifestyle and quality of life

Digital tools to inform patients about the disease, treatments, self-evaluation and self-management

Discussion

Funding

Disclosure of interest

Export

Vol 91 - N° 5

Article 105733- septembre 2024 Retour au numéro

Article précédent

Proton pump inhibitors, bone and phosphocalcic metabolism
Cécile Philippoteaux, Julien Paccou, Emmanuel Chazard, Bernard Cortet

| Article suivant

Clinical spectrum and outcome of Takayasu's arteritis in children
Nolan Hassold, Perrine Dusser, Audrey Laurent, Irene Lemelle, Pascal Pillet, Cloé Comarmond, Arsene Mekinian, Marc Lambert, Tristan Mirault, Ygal Benhamou, Alexandre Belot, Eric Jeziorski, Héloïse Reumaux, Jean Sibilia, Alexandra Desdoits, Olivier Espitia, Albert Faye, Pierre Quartier, David Saadoun, Isabelle Koné-Paut

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative - 01/10/24

Highlights

Abstract

Introduction

Methods

Results

Conclusion

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL